BioXcel LLC, 10% Owner at BioXcel Therapeutics, Inc. (BTAI), sold 946,500 shares at $30.83 ($29.2M) on 2021-06-25, disclosed to the SEC on 2021-06-29.
Open-market sale of $29.2M BTAI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.83 | 473,250 | $14.6M | 50.0% |
| 2 | $30.83 | 473,250 | $14.6M | 50.0% |
| Total | $30.83 avg | 946,500 | $29.2M | 100% |